Skip to content

Clinical trials

Observational Pancreatic Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Observational Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20122
20131
20143
20151
20163
20181
20191
20202
20211
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting8
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto6
Immunovia, Inc.2
Arbor Research Collaborative for Health1
AstraZeneca1
British Columbia Cancer Agency1
Canadian Network for Observational Drug Effect Studies, CNODES1
Celgene1
ECOG-ACRIN Cancer Research Group1
Fujirebio Diagnostics, Inc.1
George Zogopoulos1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms20
Breast Neoplasms3
Colorectal Neoplasms3
Lung Neoplasms3
Neoplasms3
Ovarian Neoplasms3
Head and Neck Neoplasms2
Hypoxia2
Liver Neoplasms2
Pancreatic Cyst2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.